GeoVax Labs
GOVXGeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara (MVA) vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at GeoVax Labs
Subscribe RSSDate | Type | Insider | Position | Ø-Price | Volume |
---|---|---|---|---|---|
4/1/2025 | Buy | Dodd, David A. | President, CEO | $1.1 | $10,800 |
3/31/2025 | Buy | Reynolds, Mark | CFO | $1.1 | $7,343 |
8/9/2024 | Buy | Dodd, David A. | President, CEO | $2.0 | $15,600 |
2/22/2024 | Buy | Dodd, David A. | President, CEO | $2.3 | $18,663 |
2/21/2024 | Buy | Dodd, David A. | President, CEO | $2.2 | $1,118 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)